Talking The Cure: Discussing how the coronavirus pandemic is affecting the pharmaceutical industry and FDA

Talking the Cure by Hogan Lovells

In this episode, Phil Katz, David Horowitz, and Jim Johnson explore the impact on industry and FDA of the agency’s decision to halt foreign inspections and take other steps that reduce international activities. They anticipate further steps by the agency and talk about how companies can strategically address the implications, which create obstacles but also opportunities.